1-20 of 2012
Clinical Trials and Observations
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dose-reduced apixaban for secondary prophylaxis in patients with severe obesity: a single center analysis

Open Access
Clinical Trials & Observations
Eliot A. Rapoport, Noelle W. Townsend, Nadine Farhat, Parth Patel, Henny H. Billett
Journal: Blood Advances
Blood Adv (2025) 9 (19): 4776–4779.
https://doi.org/10.1182/bloodadvances.2025016037
Published: 2025
Journal Articles

Characterizing clinically significant extravascular hemolysis in adults with PNH on ravulizumab or eculizumab treatment

Open Access
Clinical Trials & Observations
Austin G. Kulasekararaj, Jong Wook Lee, Christopher J. Patriquin, Caroline I. Piatek, Alexander Röth, Wilma Barcellini, Robert A. Brodsky, Jun-ichi Nishimura, Ji Yu, Mohammed Mahdi, Régis Peffault de Latour
Journal: Blood Advances
Blood Adv (2025) 9 (19): 4936–4945.
https://doi.org/10.1182/bloodadvances.2024015490
Published: 2025
Includes: Supplemental data
Journal Articles

Tocilizumab prophylaxis for patients with multiple myeloma treated with bispecific antibodies

Open Access
Clinical Trials & Observations
Andrew Kowalski, Jill Lykon, Benjamin Diamond, David Coffey, Marcella Kaddoura, Francesco Maura, James Hoffman, Abhishek Pandey, Dickran Kazandjian, Ola Landgren
Journal: Blood Advances
Blood Adv (2025) 9 (19): 4979–4986.
https://doi.org/10.1182/bloodadvances.2025016911
Published: 2025
Journal Articles

Estimating efficacy of favezelimab plus pembrolizumab relative to pembrolizumab in anti–PD-1–refractory Hodgkin lymphoma

Open Access
Clinical Trials & Observations
Philippe Armand, Pier Luigi Zinzani, John Timmerman, Nathalie A. Johnson, David Lavie, Kannan Thiagarajan, Brian G. Topp, Pallavi Pillai, Alex F. Herrera
Journal: Blood Advances
Blood Adv (2025) 9 (19): 4987–4995.
https://doi.org/10.1182/bloodadvances.2024014654
Published: 2025
Includes: Supplemental data
Journal Articles

Long-term follow-up of patients with AL amyloidosis treated on a phase 1 trial of CAEL-101

Open Access
Clinical Trials & Observations
Michael Sang Hughes, Samuel Pan, Rajshekhar Chakraborty, Jayant Raikhelkar, Mathew S. Maurer, Markus Y. Mapara, Andrew Eisenberger, Suzanne Lentzsch, Divaya Bhutani
Journal: Blood Advances
Blood Adv (2025) 9 (19): 4946–4950.
https://doi.org/10.1182/bloodadvances.2025016731
Published: 2025
Includes: Supplemental data
Journal Articles

Extravascular hemolysis in PNH

Open Access
Clinical Trials & Observations
Jeff Szer
Journal: Blood Advances
Blood Adv (2025) 9 (19): 4977–4978.
https://doi.org/10.1182/bloodadvances.2025016873
Published: 2025
Journal Articles

Long-term follow-up of venetoclax monotherapy in previously treated patients with Waldenström macroglobulinemia

Open Access
Clinical Trials & Observations
Jorge J. Castillo, Alberto Guijosa, John N. Allan, Tanya Siddiqi, Ranjana H. Advani, Catherine A. Flynn, Kirsten Meid, Nina Budano, Julia Nguyen, Andres Ramirez-Gamero, Nicholas Tsakmaklis, Zachary R. Hunter, Christopher J. Patterson, Steven P. Treon, Shayna Sarosiek
Journal: Blood Advances
Blood Adv (2025) 9 (19): 4842–4847.
https://doi.org/10.1182/bloodadvances.2025016890
Published: 2025
Journal Articles

Pirfenidone for the treatment of bronchiolitis obliterans syndrome related to chronic graft-versus-host disease

Open Access
Clinical Trials & Observations
Husham Sharifi, Carson Tyler Moss, Zayan Musa, Alexander Bell, Christian O’Donnell, Carlos Hernandez Borges, Efthymia Iliana Matthaiou, Laura Johnston, Craig J. Galban, Ajay Sheshadri, Gregory Yanik, Guang-Shing Cheng, Joe L. Hsu
Journal: Blood Advances
Blood Adv (2025) 9 (19): 5024–5037.
https://doi.org/10.1182/bloodadvances.2025016122
Published: 2025
Includes: Supplemental data
Journal Articles

Moving the needle on chronic GVHD of the lung

Open Access
Clinical Trials & Observations
Julie R. Boiko, Kenneth R. Cooke
Journal: Blood Advances
Blood Adv (2025) 9 (19): 5038–5039.
https://doi.org/10.1182/bloodadvances.2025017297
Published: 2025
Journal Articles

Safety and Efficacy of Combining Midostaurin and Gemtuzumab Ozogamicin with Induction Chemotherapy in FLT3 mutated AML

Open Access
Clinical Trials & Observations
Nigel H. Russell, Jad Othman, Oliver Sebastian Cumming, Abin Thomas, Aditya Tedjaseputra, Nicola Potter, Jelena Jovanovic, Amanda Frances Gilkes, Leona Batten, Joanna Canham, Emily L Hinson, Manohursingh Runglall, Phoebe Aucken, Panagiotis Kottaridis, James Durrell Cavenagh, Claire Arnold, Sylvie D Freeman, Mike Dennis, Steven Knapper, Richard James Dillon
Journal: Blood Advances
Blood Adv bloodadvances.2025017244.
https://doi.org/10.1182/bloodadvances.2025017244
Published: 2025
Includes: Supplemental data
Journal Articles

Hydroxyurea pharmacokinetics in children with sickle cell anemia across different global populations

Open Access
Clinical Trials & Observations
Alexandra Power-Hays, Kathryn E. McElhinney, Thomas N Williams, George Mochamah, Peter Olupot-Olupot, George Paasi, Marvin E. Reid, Angela E Rankine-Mullings, Robert O Opoka, Chandy C. John, Patrick T. McGann, Charles T. Quinn, Nieko C Punt, Luke R. Smart, Susan E. Stuber, Teresa S. Latham, Alexander A. Vinks, Russell E. Ware
Journal: Blood Advances
Blood Adv bloodadvances.2025017254.
https://doi.org/10.1182/bloodadvances.2025017254
Published: 2025
Journal Articles

Long-term outcomes of genome-edited “universal” CAR19 T cells for relapsed/refractory B-ALL at a single pediatric center

Open Access
Clinical Trials & Observations
Daniela Guardo, Avijeet Kumar Mishra, Hebatalla Rashed, Kimberly Gilmour, Stuart Adams, Danielle Pinner, Martin Sauer, Ajay Vora, Paul Veys, Vesna Pavasovic, Kanchan Rao, Waseem Qasim
Journal: Blood Advances
Blood Adv (2025) 9 (18): 4750–4754.
https://doi.org/10.1182/bloodadvances.2025016366
Published: 2025
Includes: Supplemental data
Journal Articles

Gene-edited CAR T cells: going the distance in B-ALL

Open Access
Clinical Trials & Observations
John A. Ligon, Nirali N. Shah
Journal: Blood Advances
Blood Adv (2025) 9 (18): 4755–4756.
https://doi.org/10.1182/bloodadvances.2025017508
Published: 2025
Journal Articles

Risk Biomarkers of Chronic Graft-versus-host disease in Children aged 10 years or younger and Children/adults Older than 10 years

Open Access
Clinical Trials & Observations
Anna Crawford Ferreira, Debjani Dutta, Courtney M Rowan, Jamie Renbarger, Kenneth R Cooke, Paul A. Carpenter, Robert A Krance, Christine N Duncan, Conrad Russell Y. Cruz, David A Jacobsohn, Catherine M. Bollard, Elizabeth Hill, Sophie Paczesny
Journal: Blood Advances
Blood Adv bloodadvances.2025016624.
https://doi.org/10.1182/bloodadvances.2025016624
Published: 2025
Includes: Supplemental data
Journal Articles

TRANSCAR: real-world outcomes of CD19 CAR T-cell therapy in relapsed/refractory transformed indolent lymphomas

Open Access
Clinical Trials & Observations
Pierre Stephan, Roberta Di Blasi, Louise Roulin, Jean Galtier, Julien Calvani, Véronique Meignin, Marie Donzel, Alexandra Traverse-Glehen, Elsa Poullot, Marie Parrens, Vivien Dupont, Alexandra Marquet, Steven Le Gouill, Roch Houot, Francois-Xavier Gros, François Lemonnier, Emmanuel Bachy, Catherine Thieblemont, Pierre Sesques
Journal: Blood Advances
Blood Adv (2025) 9 (18): 4693–4704.
https://doi.org/10.1182/bloodadvances.2025015834
Published: 2025
Includes: Supplemental data
Journal Articles

Ibrutinib plus rituximab vs ibrutinib monotherapy in patients with Waldenström macroglobulinemia: a pooled analysis

Open Access
Clinical Trials & Observations
Alberto Guijosa, Andres Ramirez-Gamero, Shayna Sarosiek, Andrew R. Branagan, Gottfried von Keudell, Steven P. Treon, Jorge J. Castillo
Journal: Blood Advances
Blood Adv (2025) 9 (18): 4705–4715.
https://doi.org/10.1182/bloodadvances.2025016536
Published: 2025
Journal Articles

Overall survival, conditioning, and MRD in MORPHO

Open Access
Clinical Trials & Observations
Gege Gui, Christopher S Hourigan
Journal: Blood Advances
Blood Adv bloodadvances.2025017937.
https://doi.org/10.1182/bloodadvances.2025017937
Published: 2025
Journal Articles

Age-adjusted dosing of fludarabine for lymphodepletion in CAR T-cell therapy: a clinical trial simulation study

Open Access
Clinical Trials & Observations
John C. Panetta, Aimee C. Talleur, Swati Naik, Stephen Gottschalk, Markos Leggas
Journal: Blood Advances
Blood Adv (2025) 9 (18): 4676–4682.
https://doi.org/10.1182/bloodadvances.2025015928
Published: 2025
Includes: Supplemental data
Journal Articles

Bing-Neel syndrome: a case series of 46 patients from the United Kingdom

Open Access
Clinical Trials & Observations
Oliver Tomkins, Jahanzaib Khwaja, Shiwen Koay, Nicole Japzon, Chandrashekar Hoskote, Rajeev Gupta, Robert Baker, Jindriska Lindsay, Charalampia Kyriakou, Michael P. Lunn, Shirley D’Sa
Journal: Blood Advances
Blood Adv (2025) 9 (18): 4614–4617.
https://doi.org/10.1182/bloodadvances.2025016360
Published: 2025
Journal Articles

Prospective study of immunogenicity to SARS-CoV-2 booster vaccines in multiple myeloma and Waldenström macroglobulinemia

Open Access
Clinical Trials & Observations
Andrew R. Branagan, Clifton Mo, Matthew Lei, Joshua N. Gustine, Andrew J. Yee, Elizabeth O’Donnell, Jorge J. Castillo, Omar Nadeem, Catherine Flynn, Zachary Bernstein, Rie Nakamoto-Matsubara, Kirsten Meid, Rakesh Verma, Zachary R. Hunter, Maria L. Guerrera, Galit Alter, Jill Burke, Cynthia Harrington, Emerentia Agyemang, Marilyn Gammon, Kathleen Lively, Lisette Packer, Nora Horick, Jacob Laubach, Constantine S. Mitsiades, Nikhil Munshi, Kenneth C. Anderson, Steven P. Treon, Paul G. Richardson, Noopur S. Raje, Shayna R. Sarosiek
Journal: Blood Advances
Blood Adv (2025) 9 (18): 4568–4579.
https://doi.org/10.1182/bloodadvances.2025016513
Published: 2025